David Bateman
Direttore/Membro del Consiglio presso Credo Therapies Ltd.
Provenienza dei contatti di primo grado di David Bateman
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Credo Therapies Ltd.
 Credo Therapies Ltd. Financial ConglomeratesFinance Credo Therapies Ltd. is a British dormant company that was founded in 2022.
3
| Holding Company | Financial Conglomerates | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a David Bateman tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Concordia University | College/University | Undergraduate Degree | |
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Private Equity Investor | |
Amber Therapeutics Ltd.
 Amber Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Amber Therapeutics Ltd. is a British company that develops intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology. The company is based in London, UK. and has subsidiaries in United Kingdom. The company was founded in 2020 by Aidan Harold Winston Crawley. Aidan Harold Winston Crawley has been the CEO since 2020. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
| Canada | 2 |
Settori
| Consumer Services | 2 |
| Finance | 2 |
| Health Technology | 2 |
Posizioni
| Director/Board Member | 4 |
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Liliane Chamas | 4 |
| Rebecca Murphy | 1 |
| Cristian Oancea | 1 |
- Borsa valori
- Insiders
- David Bateman
- Connessioni Società
